Pathway-Targeted Therapies in Cancer 2011
More information on Pathway-Targeted Therapies in Cancer
The recent successes of targeted therapies highlight both the opportunities and the challenges of personalizing cancer care. The combination of diagnostic tools with targeted agents can provide dramatic patient benefits, but improving the durability of clinical responses requires juxtaposition of clinical and pre-clinical studies to address the underlying disease biology. The opportunity provided by this paradigm is exemplified by our ongoing studies with RG7204, an inhibitor of V600E-BRAF.
Organizer & Venue for Pathway-Targeted Therapies in Cancer
| Other events by | Join as organizer
Organizer
Cambridge Healthtech Institute
250 First Avenue
Suite 300
Needham, MA 02494
Tel: 781-972-5400
Fax: 781-972-5425
| Other events in | Join as Venue
Venue
Moscone Convention Center
747 Howard Street, 5th Flr.
San Francisco, , USA
Tel: 415.974.4000, 415.974.4073
Fax: +1 (415) 974-4073